[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356384-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356384-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-complete-pathological-response-to-preoperative-chemotherapy-in-a-male-patient-with-primary-neuroendocrine-breast-cancer-a-case-report","A complete pathological response to preoperative chemotherapy in a male patient with primary neuroendocrine breast cancer - a case report","","Primary neuroendocrine carcinoma (small-cell carcinoma) of the breast is a rare malignancy, most often reported in women, and lacks clearly defined treatment guidelines. This case report describes a 47-year-old Syrian man who presented with a left breast mass. Histopathology confirmed high-grade small-cell carcinoma, imaging excluded other primary sites, and neoadjuvant cisplatin plus etoposide was followed by modified radical mastectomy, achieving complete pathological response. After 18 months of surveillance, the patient remained well.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-complete-pathological-response-to-preoperative-chemotherapy-in-a-male-patient-with-primary-neuroendocrine-breast-cancer-a-case-report/356384/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-complete-pathological-response-to-preoperative-chemotherapy-in-a-male-patient-with-primary-neuroendocrine-breast-cancer-a-case-report/356384.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is this case report considered rare?","Question",{"text":63,"@type":64},"Primary neuroendocrine (small-cell) carcinoma of the breast is exceedingly uncommon, especially in men, and it has no established treatment guidelines.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What diagnostic steps were used before treatment?",{"text":68,"@type":64},"Histopathological investigation identified high-grade small-cell carcinoma, and computed tomography imaging excluded other potential primary origins.",{"name":70,"@type":61,"acceptedAnswer":71},"What treatment was given and what was the outcome?",{"text":72,"@type":64},"The patient received neoadjuvant chemotherapy with cisplatin and etoposide, followed by modified radical mastectomy, resulting in a complete pathological response with continued well-being during 18 months of surveillance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356384,1790194501,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Saifo et al. Journal of Medical Case Reports (2026) 20:111  \n[https://doi.org/10.1186/s13256-025-05780-4](https://doi.org/10.1186/s13256-025-05780-4)  \nJournal of Medical Case Reports  \n CASE REPORT Open Access  \nA complete pathological response  \nto preoperative chemotherapy in a male patient with primary neuroendocrine breast cancer: a case report  \nMaher Saifo1,2, Rahaf Hussein1,2, Eva Awad1, Mohamad Al Chikh Youssef1 and Mousa Alali1,2*  \nAbstract  \nBackground Primary neuroendocrine carcinoma (small-cell carcinoma) of the breast is a rare tumor; most cases are reported in women. Small-cell carcinoma is a type of neuroendocrine tumor characterized by high-grade, poorly differentiated, and aggressive behavior, which are common features regardless of the tumor’s location. Here, we present a rare case of primary small-cell carcinoma of the breast in a male patient treated successfully with neoadjuvant chemotherapy followed by surgery.  \nCase presentation A 47-year-old Syrian man presented with a left breast mass. Further histopathological investigation revealed the diagnosis of high-grade small-cell carcinoma of the breast. Computed tomography imaging excluded other potential primary origins. The patient was treated with neoadjuvant chemotherapy (cisplatin and etoposide), followed by a modified radical mastectomy. After 18 months of diagnosis, the patient is under surveillance and doing well.  \nConclusion This report presents a rare case of male breast cancer with the uncommon histological diagnosis of small-cell carcinoma. It highlights a successful therapeutic approach in the absence of established treatment guidelines.  \nKeywords Breast cancer, Male, Small-cell carcinoma, Neuroendocrine, Complete pathological response, Case report  \nIntroduction  \nGlobally, breast cancer is the second most commonly diagnosed cancer, while in Syria it represents the most prevalent cancer (21.5% of all cases in both sexes) [1, 2]. Less than 1% of all breast cancer cases occur in men [3]. Invasive ductal carcinoma is the most frequent histologic  \n*Correspondence: Mousa Alali  \n[mousa.alali@damascusuniversity.edu.sy](mousa.alali@damascusuniversity.edu.sy); [mousa961987@gmail.com](mousa961987@gmail.com)  \n1 Faculty of Medicine, Damascus University, Fayez Mansour Street, P. O. Box: 222, Damascus, Syrian Arab Republic  \n2 Department of Oncology, Albairouni University Hospital, Damascus University, Harasta M5, Damascus, Syrian Arab Republic  \ntype of primary male breast cancer, representing about 85% of reported cases. Papillary carcinoma is the second most common subtype, accounting for approximately 2.6% of cases, and it occurs about twice as often in men compared with women. Lobular carcinoma is rare in male individuals, comprising only 1–1.5% of cases. Invasive mucinous carcinoma is also uncommon, representing just around 1% of male breast cancers [4, 5]. Neuroendocrine neoplasms arise from neuroendocrine cells distributed throughout the body, most commonly found in the gastrointestinal tract and respiratory system. Primary neuroendocrine breast carcinoma (NEBC) is exceedingly rare, constituting less than 0.1% of all breast  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by","cbCaiuhmIiD2T5oE","https://ap.wps.com/l/cbCaiuhmIiD2T5oE","pdf",1139176,"English","# Abstract\n# Background\n# Case presentation\n## Patient presentation and diagnosis\n## Treatment and follow-up\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"Why is this case report considered rare?\",\"answer\":\"Primary neuroendocrine (small-cell) carcinoma of the breast is exceedingly uncommon, especially in men, and it has no established treatment guidelines.\"},{\"question\":\"What diagnostic steps were used before treatment?\",\"answer\":\"Histopathological investigation identified high-grade small-cell carcinoma, and computed tomography imaging excluded other potential primary origins.\"},{\"question\":\"What treatment was given and what was the outcome?\",\"answer\":\"The patient received neoadjuvant chemotherapy with cisplatin and etoposide, followed by modified radical mastectomy, resulting in a complete pathological response with continued well-being during 18 months of surveillance.\"}]","A complete pathological response to preoperative chemotherapy in a male patient with primary neuroendocrine breast cancer - a case report | PDF",1790125123,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe55e09d126a1c5e551e7fd2f0e85c3e.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c840729f247a908595a837325d6cb25.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18d1f9868d229e99d8237908c078a920.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12eea1109d4ffbb6e4c4163b98dc5f24.webp",980,1301]